# Tris Pharma Inc. – FDA Inspection, Mar 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/bbcf743c-d4e0-4c1b-9f1e-81f82bd0e447
Source feed: FDA_Inspections

> FDA inspection 1010216 of Tris Pharma Inc., March 20, 2017. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010216
- Company Name: Tris Pharma Inc.
- Inspection Date: 2017-03-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: New Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1289086 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/b0a66ca1-e50e-48d8-8bb1-9e1b4802753b)
- [FDA Inspection 1232735 - 2024-03-08](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/99d56376-6034-4b6d-bb10-9c0588ba3b2d)
- [FDA Inspection 1143403 - 2021-06-08](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/0d3df2aa-17b0-4cd8-b8b1-3c73c074e44d)
- [FDA Inspection 1076980 - 2019-01-23](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/2d9231c8-f86c-4a28-96c0-54d7c9c16c2c)
- [FDA Inspection 1048300 - 2018-04-16](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/868cb111-c9ed-4744-857d-5d267514ece7)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)

Company: https://www.keypedia.com/companies/tris-pharma-inc/65a6590a-3777-454b-bf0d-a9d37e3bf58e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c